Free Trial

ADMA Biologics (ADMA) SEC Filings & 10K Form

ADMA Biologics logo
$20.22 -0.10 (-0.49%)
Closing price 04:00 PM Eastern
Extended Trading
$20.39 +0.17 (+0.82%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ADMA Biologics SEC Filings

DateFilerForm TypeView
03/21/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:40 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:05 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
8:01 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
12:51 PM
ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:10 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:15 PM
ADMA Biologics (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:06 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
8:02 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:00 PM
ADMA Biologics (Subject)
Tade Brad L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
8:00 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
8:05 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:05 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
12:34 PM
ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
8:21 AM
ADMA Biologics (Subject)
Invesco Ltd. (Filed by)
Form SC 13G
11/07/2024
4:00 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:00 AM
ADMA Biologics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/31/2024
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
8:22 AM
ADMA Biologics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
10/10/2024
8:29 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2024
4:25 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Your Wealth is Under Attack (Ad)

Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.

Click here now to see how to stop them in their tracks!
10/02/2024
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:27 PM
ADMA Biologics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
09/11/2024
8:00 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:00 PM
ADMA Biologics (Subject)
Guiheen Lawrence P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
8:00 PM
ADMA Biologics (Subject)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
8:02 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:05 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
8:26 PM
ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
8:22 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
8:00 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
8:28 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
8:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
4:00 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/26/2024
8:00 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/26/2024
8:05 PM
ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
8:10 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2024
4:15 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
3:34 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:15 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/17/2024
8:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:01 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:06 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:35 PM
ADMA Biologics (Filer)
Form DEFA14A
04/15/2024
3:40 PM
ADMA Biologics (Filer)
Form ARS
04/15/2024
3:31 PM
ADMA Biologics (Filer)
Form DEF 14A
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ADMA) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners